Lilly/Amylin amassing significant pre-launch stock of Bydureon, the once-a-week form of Byetta

Lilly/Amylin amassing significant pre-launch stock of Bydureon, the once-a-week form of Byetta. October 22nd, 2010 is the likely date Bydureon will be ready to launch. Byetta has only lost 7.7% market share to Victoza.